HON Honeywell International Inc

Dividend
2.02%
Previous close
$229.45
Est. 12 months change
+12.50%
Projected Price
$258.43

Profitability Metrics

Return on Equity (ROE)
27.34%
Return on Assets (ROA)
6.06%
Return on Invested Capital (ROIC)
11.88%
Weighted Average Cost of Capital (WACC)
8.79%
ROIC - WACC
3.08%
Updated : 2026-04-03 21:37 ET

Valuation Metrics

P/E Ratio
31.02
Forward P/E
21.78
PEG Ratio
4.92
Debt Current Ratio
1.30

Growth & Cash Flow

Gross Margin
36.93%
Operating Margin
18.22%
FCF Margin
14.48%
TTM Revenue Growth
-2.74%
Projected 12M EPS Growth
42.42%

Price Change

Price % from 50 SMA
-2.32%
Price % from 200 SMA
8.12%
6 Months
15.26%
1 Year
12.61%
2 Years
21.47%
Click here to see the list of ETFs containing HON as a top holding :HON ETFs

Analysis

Company Overview

Honeywell International is a diversified industrial conglomerate with businesses spanning aerospace technologies, industrial automation, performance materials, and energy transition. Sector: Industrials.

Overview

Honeywell International Inc (HON) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

From a returns-on-capital standpoint, ROIC is 11.88%, WACC is 8.79%, and the economic spread is 3.08%. On balance, the company clears its capital cost hurdle modestly — value creation is present but not emphatic. Supporting metrics show ROE at 27.34% and ROA at 6.06%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

The company's current market valuation reflects trailing P/E of 31.02, forward P/E of 21.78, PEG of 4.92. The trailing-to-forward compression is present but not extreme — consistent with a company where earnings are expected to grow at a steady rather than exceptional pace. Growth-adjusted valuation is stretched here — the multiple implies either above-consensus growth or a willingness to pay a premium for quality. The aggregate current ratio of 1.30 points to tighter short-term liquidity across the company. Across multiples and liquidity, the company is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

Margins & Cash Generation

On profitability at each income statement layer, gross margin sits at 36.93%, operating margin at 18.22%, and free cash flow margin at 14.48%. Gross margins are moderate, pointing to the company where unit economics are functional but not a source of structural advantage. At this operating margin level, the the company demonstrate competent cost management and reasonable earnings durability. Free cash flow margins are moderate, with a meaningful but not exceptional share of revenue converting to cash after capex. Taken together, margins are adequate but uneven, suggesting earnings quality is not uniformly strong across all levels.

Growth & Forward Outlook

Looking at growth and market-implied direction, TTM revenue growth of -2.74% reflecting difficult operating conditions that are showing up in aggregate top-line numbers. At the same time, the estimated 12-month price change of 12.63%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Putting the pieces together, this is a profile with genuine merit: the numbers support confidence in the forward case without requiring heroic assumptions.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.